A systematic review of the effects of CYP2D6 phenotypes on risperidone treatment in children and adolescents

• Egile Nagusiak: Thomas Dodsworth (Egilea), David D. Kim (Egilea), Ric M. Procyshyn (Egilea), Colin J. Ross (Egilea), William G. Honer (Egilea), Alasdair M. Barr (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2018-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract The second generation antipsychotic drug risperidone is widely used in the field of child and adolescent psychiatry to treat conditions associated with disruptive behavior, aggression and irritability, such as autism spectrum disorders. While risperidone can provide symptomatic relief for m...